CTSB and breast carcinoma: To the best of our knowledge this is the first time that photoactivation of a caged inhibitor of CTSB has been demonstrated to block proteolysis at the surface of living cancer cells, in this case living breast cancer cells grown in 3D MAME models that recapitulate the in vivo microenvironment of human breast tumors [32–33].